Not only did CYP3A4 knockdown reverse the augmentation of BMSC‐mediated chemoprotection that is associated with MRD biology (ie chemotherapy effect including low leukaemia burdens and diminished inflammation), but the CYP3A4 inhibitor clarithromycin had similar activity. Here, CYP3A4 is linked to leukemia.